Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

61results about How to "Promote tissue repair" patented technology

Native soft tissue matrix for therapeutic applications

InactiveUS20050288796A1Promote ex vivo regenerationEfficient and effectiveAnti-incontinence devicesPharmaceutical delivery mechanismTissue repairPerichondrium
A product for implantation within a soft tissue site of the human or animal body comprises a pulverized or morselized matrix of a substantially non-mineralized native soft tissue (NSTM) of the human or animal body, provided in a therapeutic amount to induce growth of native tissue or organs and healing at the tissue site. The NSTM is composed of at least one soft tissue selected from the group consisting of cartilage, meniscus, intervertebral disc, ligament, tendon, muscle, fascia, periosteum, pericardium, perichondrium, skin, nerve, blood vessels, and heart valves or from organs such as bladder, lung, kidney, liver, pancreas, thyroid, or thymus. Preferably, the NSTM is composed of a soft tissue of the same type of tissue native to the repair site. In another embodiment, the NSTM includes soft tissue of a different type than the tissue repair site.
Owner:AWAD HANI +2

Methods

InactiveUS20110044997A1Reduce unwanted side effectPreventing agonism of unnecessary targetsBiocideNervous disorderProgenitorCXCR4
The current invention provides a method for mobilising endothelial progenitor cells (EPC) and / or mesenchymal stem cells (MSC) in a patient, wherein the method comprises the steps of (i) administering a vascular endothelial growth factor receptor (VEGFR) agonist to the patient; and (ii) administering an antagonist of CXCR4 to the patient. Also provided are uses of EPC and MSC harvested using the methods of the invention.
Owner:IMPERIAL INNOVATIONS LTD

External magnetic force for targeted cell delivery with enhanced cell retention

InactiveUS20120253102A1Function increaseIncreased cardiac outputElectrotherapyBalloon catheterCell deliveryBiology
Disclosed herein are compositions and methods for the improved delivery of cells to a target tissue. In some embodiments, the compositions comprise stem cells, in particular cardiac stem cells, and the target tissue is damaged or diseased cardiac tissue. In several embodiments, the methods, in combination with the compositions, yield enhanced delivery, retention, and / or engraftment of the cells into the target tissue, thereby inducing improved functional recovery.
Owner:CEDARS SINAI MEDICAL CENT

Methods of treating tissue defects

Methods of treating tissue defects, including defects such as bone fractures, vertebrae fusions, and spinal disc repair, using electric or electromagnetic fields and growth factors. In various embodiments, the present invention provides methods for the treatment of a human or other mammal subject in need thereof, by administering electric stimulation and growth factors to stimulate endogeneous stem cells in the subject to facilitate healing. Other embodiments include methods of administering electric stimulation, growth factors, and stem cells to the defect. In various embodiments the amount of growth factor is a subefficacious amount.
Owner:EUROPEAN BIOINFORMATICS INSTITUTE

Therapeutic encapsulated embryonic stem cells and mesenchymal stromal cells

This application discloses alginate microencapsulation-mediated differentiation of embryonic stem cells and use of the stem cell differentiation method for the development of effective treatment of various diseases and disorders. The microencapsulation of embryonic stem (ES) cells results in decreased cell aggregation and enhanced neural lineage differentiation through incorporating the soluble inducer retinoic acid (RA) into the permeable microcapsule system. This application also discloses a micro-encapsulation system for immobilizing mesenchymal stromal cells (MSCs) while sustaining the molecular communication. Thus, the invention provides the use of encapsulated mesenchymal stromal cells in the cellular transplantation therapies. Moreover, the invention provides methods for delivery of encapsulated MSCs into the central nervous system and therapies derived therefrom, such as, the treatment of spinal cord injury (SCI) and other inflammatory conditions.
Owner:RUTGERS THE STATE UNIV

Biological lysozyme compound preparation and preparation method thereof

The invention relates to a biological lysozyme compound preparation and a preparation method thereof. The preparation method comprises the following steps: dissolving lysozyme, amino acid, proteolytic enzyme, lysostaphin and peroxidase in water according to a certain proportion, transferring the mixed solution into a mixing tank, adding sorbitol, hydrated silica, aluminium hydroxide, glycerol, sodium lauroyl sarcosine, edible essence, cellulose gum, carrageenan, hydroxyethyl cellulose, sodium phytate, saccharin sodium, strontium chloride, trisodium phosphate, borneols, sodium borate, cinnabar, natrii sulfas exsiccatus and allantoin according to corresponding proportion, reacting for 47-49 h under a constant temperature condition of 38-42 DEG C to prepare the activated biological lysozyme compound preparation finished product. The biological lysozyme compound preparation belongs to a novel non-hormonic and non-antibiotic protein function preparation, has extremely great capacities of bacteriolyzing, reducing inflammation and enhancing immunity, and various effects of resisting various infections and promoting rehabilitation.
Owner:JIANGSU XUE BAO DAILY CHEM CO

Nerve growth factor sponginum and preparation method thereof

The invention relates to a nerve growth factor sponginum and a preparation method thereof, belonging to the technical field of medicine. The sponginum comprises nerve growth factor with weight percent content being 0.01-2% and collagen sponge or gelatin sponge matrix, the nerve growth factor is fixed on the collagen sponge or gelatin sponge matrix in a crosslinking way by an aldehydes crosslinker. The sponginum can cause the nerve growth factor to be released to the nerve pathology or wound tissue partial position continuously for a long time in effective dose, and play a role in effectively curing nerve tissue damage.
Owner:WUHAN HITECK BIOLOGICAL PHARMA

Medical and recreational magnetic device and method of using it

A medical and recreational devise comprises at least two laminas. The laminas comprises sources of magnetic field. The sources of the magnetic field located on one of the laminas faced to another one completely or partially by like and / or unlike magnetic poles, and at least one of said laminas are congruent to a treated part of body and attached to the treated part of body. A method of using said medical and recreational devise comprises the step: attached at least one of said laminas to the treated part of body, attached to lower or upper extremity to unload the affected extremity, and attached another set of said laminas to a bed parallel to the first one. The magnets embedded in said laminas attached to an affected part of the extremity faced to like poles to the magnets embedded to said laminas attached to the bed.
Owner:FRIBERG WALTER

Wound repair composition and preparation method and application thereof

The invention provides a wound repair composition. A formula of the wound repair composition comprises the following components in percentage by weight: 10-50 percent of chitosan mucilage, 10-50 percent of an extracting solution of a staphylococcus aureus metabolic product and 0-80 percent of medicament auxiliary materials, wherein the chitosan mucilage is a solution consisting of chitosan and an aqueous solution of an acid; the volume concentration of the acid in the aqueous solution of the acid is 0.8-1.2 percent; and the mass concentration of the chitosan in the chitosan mucilage is 1-3 percent. The invention further provides a preparation method of the wound repair composition and an application thereof as a medicament for treating skin or mucosal injure. The wound repair composition provided by the invention has the advantages of capabilities of promoting tissue repair, promoting wound healing and promoting the growth of epidermal cells, good infection inhibiting effect, high biocompatibility, realization of flat healed wounds, freeness from adverse side reactions, relieving in patient pain, convenience for nursing and using, easiness for storing, and the like.
Owner:SHANGHAI RUNZHI BIOTECH

Growth factor modified extracellular matrix material and methods for preparation and use thereof

Described are tissue graft constructs that include submucosa and other extracellular matrix materials that incorporate a number of exogenous proteins. Further described are methods for making tissue graft constructs that include stripping endogenous heparin binding proteins from a porcine graft material and thereafter binding one or more human growth factors to the native heparin molecules that are retained within the graft material. Such graft materials may be used in methods for the treatment of wounds in patients.
Owner:COOK BIOTECH

Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer

The invention discloses activated carbon infusion solution, preparation method therefore and use thereof for the manufacture of drug for treating cancer. The activated carbon infusion solution contains pure activated carbon microparticles injection solution, activated carbon microparticles injection solution, activated carbon injection solution adsorbing catalyst and various injection solutions carrying drugs, all of which are for intravenous use. It characterizes that the surface area of material activated carbon used is greater than or equal to 400-10000 M2 / g or higher, heavy metal content is less than or equal to 0.1-10 ppm, other dissoluble metal ion content is less than or equal to 0.1-10 ppm, crozzle is less than 2%, total pore cubage is greater than 0.3-6 cm2 / g, 0.15% methylene blue adsorptive value is greater than 6-30, the diameter of the activated carbon microparticles contained in this activated carbon infusion solution are ranged from 35 μm to 2 nm, the diameters are mainly ranged from 6 μm to 3 μm are not more than 1%, the microparticles which greatest diameter is 35 μm to 6 μm have not more than 2×104 / mg activated carbon micropowder. When this activated carbon microparticles are intravenously injected into blood, they have good compatibility with tissues, have no toxicity or side effect, have no harmful stimulation, have no immunogenicity, they are safe and effective. They have incredible curative effect in treating cancer, blood vessels, atherosclerosis, coronary heart disease, cerebral thrombosis, infectious diseases, azotemia, acute organic and inorganic poison poisoning.
Owner:CHEN XIAOCHUAN +1

Acne removal composition and acne removal skin-care product

The invention discloses acne removal composition. The acne removal composition comprises components in parts by weight as follows: 5-10 parts of oil-absorption powder, 75-85 parts of fresh aloe juice, 3-8 parts of royal jelly extract, 2-10 parts of danshen root extract, 1-5 parts of liquorice extract, 1-5 parts of laminaria saccharina extract, 1-5 parts of plant flower extract and 1-5 parts of allantoin. The invention further discloses a skin-care product using the acne removal composition. The acne removal composition can reduce secretion of grease, absorb skin grease, has good effects of acne removal, scar removal and promotion of skin recovery, can be used for preventing and treating acnes, has remarkable effect and takes effect quickly, and no acne marks are left after acnes are healed.
Owner:吴颖斯

Antimicrobial compositions containing free fatty acids

The invention concerns antimicrobial compositions comprising free fatty acids emulsified with membrane lipids or hydrolysed derivatives thereof, and pharmaceutical formulations comprising same. The compositions can be used in the treatment of prophylaxis of microbial infections. They can also regulate the rate of blood clotting rendering them suitable for incorporation in catheter locking solutions and for use in wound care.
Owner:FOLAN MICHAEL ANTHONY

Adipose-derived mesenchymal stem cell factor lyophilized powder and preparation method thereof

The invention provides adipose-derived mesenchymal stem cell factor lyophilized powder and a preparation method thereof. According to the method, an adipose-derived mesenchymal stem cell is cultured by adopting conditions of mechanical stimulation and hypoxic stimulation, the secretion of stem cell factors is promoted, the reasonable cooperation of polyethylene glycol, konjak sugar, proline, glutathione, sodium benzoate, sodium dodecyl sulfate and tetrahydro-2-pyrimidinone is adopted to serve as a lyophilized powder protective agent, and the prepared adipose-derived mesenchymal stem cell factor lyophilized powder has good stability, stem cell factor content and activity.
Owner:GUANGZHOU RAINHOME PHARM&TECH CO LTD

Antimicrobial compositions containing free fatty acids

The invention concerns antimicrobial compositions comprising free fatty acids emulsified with membrane lipids or hydrolyzed derivatives thereof, and pharmaceutical formulations comprising same. The compositions can be used in the treatment of prophylaxis of microbial infections. They can also regulate the rate of blood clotting rendering them suitable for incorporation in catheter locking solutions and for use in wound care.
Owner:FOLAN MICHAEL ANTHONY

Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use

InactiveUS20160376318A1Promotion of tissue repairPromotion of wound healingAntibacterial agentsBiocideWound healingDisease
A polypeptide, a DNA molecule encoding the polypeptide, a vector, a preparation method and a use therefor are disclosed. The polypeptide comprises an amino acid sequence represented by formula (I) or formula (II): formula (I) comprises an amino acid sequence represented by SEQ ID NO: 1; formula (II) comprises an amino acid sequence obtained by subjecting the amino acid sequence represented by SEQ ID NO: 1 to modification, substituted, and deletion or addition of one or more amino acids. The polypeptide may be used in the preparation of drugs that treat or prevent diseases related to infections caused by bacteria, and can also be used in the preparation of drugs that promote tissue repair and wound healing.
Owner:WUHAN MORE BIOTECH

Recombined ternary fused collagen and application thereof

The invention discloses recombinant ternary fusion collagen and its application, belonging to the field of genetic engineering. The recombinant ternary fusion collagen includes recombinant human-like collagen and new lactobionic acid with a mass ratio of 25-35%; the recombinant human-like collagen is formed by fusing human-like collagen with 3GF growth factor, which includes A first region with at least 80% sequence homology of human-like collagen and a second region with at least 80% sequence homology with each human cell growth factor, and a connecting peptide is arranged between the first region and the second region. Compared with the traditional human-like collagen, it is easier to be absorbed by the human body. The fusion collagen provided by the present invention is absorbed faster and more thoroughly. At the same time, it can also promote human metabolism, wound healing and tissue repair, yellowing, skin rejuvenation, and improvement Melasma, freckles and other pigmentation, wrinkles and skin tone effect, is a breakthrough new fusion collagen with comprehensive effects.
Owner:湖南萨可生物医药有限公司

Extracellular matrix gel carrying mesenchymal stem cell exosome and preparation method thereof

The invention discloses extracellular matrix gel carrying mesenchymal stem cell exosomes and a preparation method thereof. The mesenchymal stem cell-derived exosome is extracted and is mixed with the extracellular matrix and the methylacryloylated gel, so that the mesenchymal stem cell-derived exosome has uniformity and formability, the biological activity of the mesenchymal stem cell is retained, and a new thought is provided for a biological material tissue repair preparation.
Owner:THE AFFILIATED SIR RUN RUN SHAW HOSPITAL OF SCHOOL OF MEDICINE ZHEJIANG UNIV

Functional scaffold for tissue repair and regeneration

A biocompatible scaffold is provided that includes a biocompatible scaffold substrate and an amount of a demethylation agent or a methylation inhibitor, in an amount effective to induce and / or promote tissue repair and regeneration. The demethylation agent or methylation inhibitor can be a cytidine analog. The scaffold can further include an effective amount of one or more of a target specific growth factor, a cytokine, a signaling molecule or a pharmaceutically acceptable carrier. The scaffold can be constructed of a natural or non-natural material; one alternative is a gel formed by the catalytic activity of transglutaminase.
Owner:HAN BO

Extracellular matrix for tissue reconstruction of mucosal tissue

InactiveUS20190184060A1Promote healingFacilitate constructive remodelingSurgical adhesivesSurgical drugsGynecologyTissue repair
Described are methods and compositions for treatment of reproductive or urogenital mucosal tissue damage using Extracellular Matrix (ECM) solution and, particularly, Extracellular Matrix Hydrogel (ECMH) solution delivered to the target site for tissue repair, restoration, remodeling, or reconstruction.
Owner:REGENTYS CORP

Anastomotic/occlusion reinforcing and repairing composite member as well as preparation and application method thereof

The present disclosure relates to the technical field of medical equipment and discloses an anastomotic / occlusion reinforcing and repairing composite member which includes a reinforcing and repairing portion, a protection portion and a connecting thread, wherein two ends of the reinforcing and repairing portion are detachably connected by the connecting thread; and the protection portion penetrates into a space enclosed by the two ends of the reinforcing and repairing portion. The present disclosure also provides a preparation and application method of the anastomotic / occlusion reinforcing and repairing composite member.
Owner:BEIJING BIOSIS HEALING BIOLOGICAL TECH

Microballons/nanometer yarn composite bracket loaded with exosomes and growth factors and preparation method of microballons/nanometer yarn composite bracket

The invention relates to a microballons / nanometer yarn composite bracket loaded with exosomes and growth factors and a preparation method of the microballons / nanometer yarn composite bracket. The composite bracket is prepared by that the microballons are adhered to the surface of nanometer yarn, wherein the nanometer yarn is nanometer yarn adopting a core / shell structure; and the microballons arepolylactic acid glycolic acid copolymer microballons of which the inner parts are loaded with fibroblast growth factors. The microballons / nanometer yarn composite bracket disclosed by the invention has high stretch mechanical property and excellent biocompatibility; the structure of the nanometer yarn has larger aperture; tissue repair can be promoted by the exosomes loaded by a fiber core layer,and three-dimensional infiltration of urinary tract relevant cells is facilitated; and the microballons can release fibroblast growth factors, so that the microballons / nanometer yarn composite bracketcan be applied to fields of tissue engineering urethra and the like.
Owner:DONGHUA UNIV

Method and equipment for preparing tissue engineering scaffold with anisotropic pore structure

The invention discloses a method for preparing a tissue engineering scaffold with an anisotropic pore structure. The method comprises the following steps of: placing polymer solution and porogen into specific equipment; performing heat exchange of subzones by using a plurality of temperature zones and the polymer solution, and precisely controlling the temperature change curves and the heat exchange directions of the polymer solution and the porogen; and fixing the phase separation degree, removing the porogen and solvent and drying. The method can realize precise and controllable anisotropism of the pore structure inside the scaffold by performing the precise and controllable heat exchange of the subzones on the prepared polymer scaffold so as to meet the requirements of tissue engineering application and improve the repairing effect. In addition, the invention also discloses equipment for implementing the method.
Owner:GUANGZHOU SUN SHING BIOTECH CO LTD

Compositions for regenerating tissue that has deteriorated, and methods for using such compositions

A composition for promoting regeneration of tissue which has degenerated in a subject as a result of a disease or disorder and a method of using the composition is provided. The composition comprises a biodegradable acellular matrix, and passaged autologous fibroblasts substantially free of immunogenic proteins, e.g., culture medium serum-derived proteins, integrated within the matrix. The method of using the composition to promote regeneration of tissue involves placing the composition on a site of degenerated tissue in a subject so that the composition promotes tissue regeneration at the site. The composition and the method of its use have applications promoting regeneration of tissue (i) that has degenerated as a result of numerous diseases or disorders or (ii) that has a defect, including, but not limited to, defects of the oral mucosa, trauma to the oral mucosa (e.g., extraction of a tooth), periodontal disease, diabetes, cutaneous ulcers, venous stasis, scars of the skin, or wrinkles of the skin. Also provided is an injectable composition comprising any type of collagen and passaged autologous fibroblasts substantially free of immunogenic proteins, e.g., culture medium serum-derived proteins, for correcting defects in skin, such as wrinkles or scars, and for augmenting tissue in the subject, particularly facial tissue.
Owner:ISOLAGEN INT

Method for obtaining a cytokine-rich composition and composition obtained by means of this method

The invention relates to a method for preparing serums, said serums comprising cytokines and coagulation factors, and for preparing fibrin gel compositions, wherein the method comprises submitting an isolated biological sample comprising platelets and / or leukocytes to different steps of different gravity force to obtain supernatants with high concentrations of cytokines and coagulation factors. The invention also encompasses serums obtainable by this method, and other derived products comprising them. Uses of the products are disclosed, in particular its use as tissue regeneration.
Owner:NTE SENER HEALTHCARE SA

Medical and recreational magnetic device and method of using it

A medical and recreational device comprises at least two laminas. The laminas comprise sources of magnetic field. The sources of the magnetic field located on one of the laminas faced to another one completely or partially by like and / or unlike magnetic poles and at least one of said laminas configured to be attached to the treated body part.
Owner:FRIBERG WALTER

Degradable toothbrush main material with self-cleaning function

PendingCN112267169ARestoration of the mouthProtect the mouthBristleFilament/thread formingElectrospinningPanax notoginseng extract
The invention provides a degradable toothbrush main material with a self-cleaning function. The toothbrush main material is prepared by the following steps of mixing chitosan, a radix notoginseng extract, a honeysuckle extract, carboxymethyl chitosan, a nanomaterial, biotin, lysine and collagen to prepare a mixed solution; adding a degradable resin material, and carrying out a cross-linking reaction under the action of a cross-linking agent to prepare a textile material; adding polybutylene terephthalate, a lubricant, an antioxidant and polyethylene glycol 200, and performing fusing, dissolving, extruding and cooling to obtain textile particles; and carrying out electrostatic spinning. According to the invention, nanoparticles are adopted to cooperate with the radix notoginseng extract andthe honeysuckle extract, so that the plasticity and elasticity of the material are enhanced, and the self-cleaning, bacteriostasis and efficient decontamination effects of the toothbrush main material are realized; and therefore, the toothbrush main material ensures the oral health of people and is suitable for commercial popularization.
Owner:湖南翰坤实业有限公司

Small needle knife

The invention provides a small needle knife composed of a needle knife handle, a needle knife body and a needle knife blade connected one by one. The needle knife handle is in the shape of a horse shoe. A cylindrical needle knife tail is arranged on the tail end of the needle knife handle. When the needle knife is used, the cylindrical needle knife tail arranged at the front end of the needle knife handle allows a moxa cone to be installed on the needle knife tail for heating when the needle knife is retained in vitro partially, so that through thermal conduction, the amount of bleeding is reduced after the needle knife cuts tissues, aseptic inflammation of the diseased tissues is eliminated, muscle spasms at parts attached to bones are eliminated and relieved, and thus tissue adhesion can be more effectively loosened and softened. Meanwhile, the needle knife can warm channels and relax collaterals, and improve tissue repair of wounded parts. The needle knife can reduce the pain of patients, and integrates the treatment functions of a needle knife and a silver needle, so that the medical costs of the patients can be reduced. The design of the horse-shoe-shaped needle knife handle reduces the area of the needle knife handle and the weight of the needle knife tail, so that the needle knife body is prevented from tilting due to overweight of the needle knife tail, and the needle knife is very convenient for use.
Owner:王鹏

Growth factor modified extracellular matrix material preparation and methods for preparation and use thereof

Described are tissue graft constructs that include submucosa and other extracellular matrix materials that incorporate a number of exogenous proteins. Further described are methods for making tissue graft constructs that include stripping endogenous heparin binding proteins from a porcine graft material and thereafter binding one or more human growth factors to the native heparin molecules that are retained within the graft material. Such graft materials may be used in methods for the treatment of wounds in patients.
Owner:COOK BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products